| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/21/2009 | US7521531 Methods for the purification of stable radioiodine conjugates |
| 04/21/2009 | US7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
| 04/21/2009 | US7521481 administering to subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof; for treating or preventing condition of central or peripheral nervous system or systemic organ associated with a disorder in protein folding or aggregation, or amyloid formation |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/16/2009 | WO2009049184A2 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors |
| 04/16/2009 | WO2009027707A3 Methods for preparing peptides, especially radio-labelled peptides |
| 04/16/2009 | WO2007014237A3 Radioprotective agents |
| 04/16/2009 | WO2007005935A3 Norepinephrine transporter radiotracers and methods of syntheses thereof |
| 04/16/2009 | WO2006127842A3 Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease |
| 04/16/2009 | WO2006110889A3 Multi-layer structure having a predetermined layer pattern including an agent |
| 04/16/2009 | WO2006096393A3 Coagulator with gamma ray detector |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | US20090098048 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor |
| 04/16/2009 | US20090098047 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 04/16/2009 | US20090098046 Combination Cancer Therapy with Anti-PSMA Antibodies |
| 04/16/2009 | US20090098045 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 04/16/2009 | US20090098044 Solid particles from controlled destabilisation of microemulsions |
| 04/16/2009 | CA2702314A1 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors |
| 04/15/2009 | EP2046397A2 Method for radiolabeling formulations for gamma scintigraphy assesment |
| 04/15/2009 | EP2046396A2 Methods and agents for preparing 18f-radiolabeled fluorinating agents |
| 04/15/2009 | EP2046288A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 04/15/2009 | EP1156835B1 Method for radiolabeling proteins with yttrium-90 |
| 04/15/2009 | CN101407545A 131I labeled anti-tumor humanized monoclonal antibody 1E2 and use thereof |
| 04/15/2009 | CN101407543A Labelled glutamine and lysine analogues |
| 04/15/2009 | CN100478380C Chemical preparation method of hollow polymer microsphere with controllable open pores |
| 04/15/2009 | CN100478035C Stabilzation of radiopharmceuticals labeled with 18-F |
| 04/14/2009 | US7517964 RS7 antibodies |
| 04/14/2009 | US7517701 Luminescent lanthanide complexes |
| 04/14/2009 | US7517528 Method and composition for treating skin wounds with epidermal growth factor |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 04/09/2009 | WO2009046294A2 Treatment of proliferative disorders using antibodies to psma |
| 04/09/2009 | WO2009046281A2 Injectable particles |
| 04/09/2009 | WO2009045230A1 Compositions for treatment of tumors by direct administration of a radioisotope |
| 04/09/2009 | WO2009043166A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/09/2009 | WO2008060845A3 Radiolabeled vitamin b12 and its derivatives useful for positron emission tomography imaging |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005077071A3 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092598 administering anti-CEA (carcinogenicembryonic antigen) monoclonal antibody (MAb) or fragment and a drug selected from vincristine, doxorubicin, dacarbazine (DTIC), cyclophosphamide, CPT-11, oxaliplatin, gemcitabine and 5-fluorouracil/leucovorin |
| 04/09/2009 | US20090092549 Miniaturized liquid surface reactions using nanomolar amounts of concentrated [11c]carbon dioxide in a stationary gas-phase |
| 04/09/2009 | US20090092548 Methods And Compounds For Targeting Tissues |
| 04/09/2009 | US20090092547 Injectable Particles |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092544 Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody |
| 04/09/2009 | US20090092543 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 04/09/2009 | US20090092542 Bioinert tissue marker |
| 04/09/2009 | DE10346228B4 Herstellung von [18F]fluormarkierten aromatischen L-Aminosäuren Preparation of [18F] fluorine labeled aromatic L-amino acids |
| 04/09/2009 | CA2701537A1 Compositions for treatment of tumors by direct administration of a radioisotope |
| 04/09/2009 | CA2700860A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | CA2700410A1 Treatment of proliferative disorders using antibodies to psma |
| 04/08/2009 | EP2044961A2 Phospholipid analogues for the treatment of cancers |
| 04/08/2009 | EP2044960A2 Phospholipid analogues for the treatment and diagnosis of cancers |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2044119A1 Cancerous disease modifying antibodies |
| 04/08/2009 | EP1505076B1 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 04/08/2009 | EP1389209B1 Folate mimetics and folate-receptor binding conjugates thereof |
| 04/08/2009 | CN101402686A Antihuman Endoglin single-chain antibody, preparation and uses thereof |
| 04/08/2009 | CN101401944A Method of preparing iodine-125 sealing seed source core |
| 04/08/2009 | CN100475826C 99mTcN nuclear marked piperazine famicid salt complex, preparation and use thereof |
| 04/08/2009 | CN100475272C Stabiliser for radiopharmaceuticals |
| 04/08/2009 | CN100475271C Somatostatin analogs with inhibitory activity to growth hormone release |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514068 Biphenyl-pyrazolecarboxamide compounds |
| 04/07/2009 | US7514067 Complexing enzyme with antibody; trapping within tumor |
| 04/07/2009 | US7514066 Targeted combination immunotherapy of cancer and infectious diseases |
| 04/07/2009 | CA2457564C Particle immobilized coatings and uses thereof |
| 04/07/2009 | CA2312767C Drug delivery system with two-step targeting |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/02/2009 | WO2009040727A2 Method of differentially diagnosing by spect different types of dementia |
| 04/02/2009 | WO2009040377A2 Radiolabelled 1, 4 -dihydro-4 -oxo-quinoline 3-carboxylic acid derivatives for pet and spect imaging, and in-vitro detection of the gaba-a receptor |
| 04/02/2009 | US20090087865 Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus |
| 04/02/2009 | US20090087379 Radiofluorinated Compounds and their Preparation |
| 04/02/2009 | US20090087378 Positron Tomography Method and Positron-Emitting Compound to Be Used Therein |
| 04/02/2009 | US20090087377 Compositions for targeted imaging and therapy |
| 04/02/2009 | US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease |
| 04/02/2009 | US20090087375 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/01/2009 | EP2042501A1 Novel compound having affinity for amyloid |
| 04/01/2009 | EP2040541A1 Adjuvants and methods of use |
| 04/01/2009 | EP1994163A4 Inhibition of breast carcinoma stem cell growth and metastasis |
| 04/01/2009 | EP1594869B9 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/01/2009 | EP1381396B1 Tc and re labeled radioactive glycosylated octreotide derivatives |
| 04/01/2009 | CN101400371A Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 04/01/2009 | CN101397659A Technique for preparing coating of iodine-125 sealed seed source silver carrier rod |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 03/31/2009 | US7511119 PRAME peptide analogues |
| 03/31/2009 | US7511118 Analogs of peptides corresponding to class I major histocompatibility complex (MHC)-restricted T-cell epitopes that contain amino acid substitutions of norleucine and/or norvaline; intranodal administration a an immunopotentiating agent |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510698 Adjuvant formulation consisting essentially of a metabolizable oil and alpha tocopherol in emulsion for enhancing immune response to infection |
| 03/26/2009 | WO2009039207A1 Method for imaging and treating organs and tissues |
| 03/26/2009 | WO2009039192A2 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/26/2009 | WO2009039125A1 Use of ocular neuropeptides as immune adjuvants |